NSE · JSLL · Pharmaceuticals
Jeena Sikho Lifecare Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹216 Cr with net profit ₹45 Cr — a 21.04% net margin, versus 30.1% the period before.
Shareholding
As of 2026-06-30
- Promoter63.62%
- Public31.24%
- FII4.78%
- DII0.36%
43,413 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.73× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #18 of 666 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,93,134 Cr | 24.35 | 4.83 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,50,307 Cr | 380.39 | 10.23 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,55,805 Cr | 90.27 | 22.31 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹95,050 Cr | 1229.26 | 66.09 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹51,354 Cr | 57.7 | 6.92 | 11.32% | 6.61% |
| Premier Energies Limited | ₹46,348 Cr | 100.69 | 10.74 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹44,672 Cr | 108.87 | 7.38 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹39,968 Cr | 236.01 | 21.29 | 19.61% | 8.72% |
| Redington Limited | ₹21,624 Cr | 55.21 | 2.13 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,658 Cr | 211.5 | 10.38 | 14.16% | 8.36% |
| Jeena Sikho Lifecare Ltd.(this company) | ₹7,098 Cr | 157.3 | 15.2 | 47.5% | 27.68% |
AI analysis
AI-generated · google/gemini-2.5-flashJeena Sikho Lifecare Ltd. is listed with a market capitalization of Rs 7031 Cr. The company reported a revenue of Rs 475.48 Cr.
Positives
- +The company has a low debt-to-equity ratio of 0.02.
- +Return on capital employed (ROCE) is 52.11%, indicating efficient use of capital.
- +Promoter holding at 63.62% is substantial.
- +Return on equity (ROE) is 39%, reflecting good profitability relative to shareholders' equity.
Negatives
- −No dividend yield information is available.
- −No revenue growth percentage is provided.
- −Quarterly net profit decreased to Rs 45.13 Cr in Mar 2026 from Rs 66.66 Cr in Dec 2025.
- −Promoter holding decreased from 67.91% in November 2023 to 63.62% in March 2026.
Financial performance
For the quarter ending March 2026, Jeena Sikho Lifecare Ltd. recorded a revenue of Rs 215.55 Cr and a net profit of Rs 45.13 Cr. This marks a decrease from the December 2025 quarter, where revenue was Rs 221.68 Cr and net profit was Rs 66.66 Cr. Over the last four reported quarters, revenue has increased from Rs 139.25 Cr in March 2025 to Rs 215.55 Cr in March 2026.
Profitability & returns
Jeena Sikho Lifecare Ltd. achieved a return on equity (ROE) of 39% and a return on capital employed (ROCE) of 52.11%. The company's earnings per share (EPS) stands at Rs 36.5. Detailed profit margins are not available in the provided data.
Balance sheet
The debt-to-equity ratio for Jeena Sikho Lifecare Ltd. is 0.02, indicating low leverage. The book value per share is Rs 109.82. No further information regarding assets or liabilities is available in the provided data.
Ownership & pledges
As of March 31, 2026, promoters held 63.62% of the company's shares. Public shareholding was 29.76%, while Foreign Institutional Investors (FIIs) held 6.17%. Domestic Institutional Investors (DIIs) held 0.46%. There were no promoter shares reported as pledged.
Regulatory & surveillance
There is no information provided regarding any regulatory actions or surveillance measures concerning Jeena Sikho Lifecare Ltd.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.